Title: Chickenpox Cases Down 85 Percent Since 2-Dose Vaccine Started: CDC
Category: Health News
Created: 9/1/2016 12:00:00 AM
Last Editorial Review: 9/2/2016 12:00:00 AM…
To learn more visit: MedicineNet Daily News
A 60-something woman had syncope and was unconscious for a few minutes. It was not a seizure. EMS found her lethargic and short of breath but without chest pain. Pulse was 103, BP 100/60, and O2 saturation on room air 98%.
She was brought to the ED, where her SpO2 was 93%, BP 88/48, pulse 100.
On arrival in the ED, she underwent an immediate bedside cardiac ultrasound:</b…
To learn more visit: Dr. Smith’s ECG Blog
Older people with multiple health problems often call a 999 ambulance. Where one of these health problems is dementia, the risk of ambulance use, A&E attendance and hospital admission are all increased. It is important to try and reduce this, as patients with dementia tend to have poor outcomes when they are taken to A&E or admitted to hospital unnecessarily.
This study aims to find out why older people with multiple health issues including dementia are taken to hospital by am…
To learn more visit: Emergency Medicine Journal current issue
Dr. Randy Katz, Director of the Memorial Regional Hospital ER, discusses which patients should come to the hospital prior to a storm’s approach. Video Rating: / 5
http://www.arthritistreatmentcenter.com
Biologics going down in price? Maybe… coming up next
First biosimilar biologic approved in Europe.
Reported in Value-based Rheumatology, an article indicating the European Commission has approved the first biosimilar biologic for the treatment of rheumatoid arthritis. Two versions, Remsima and Inflectra are copies of the popular drug Remicade. Approval of biosimilars may herald the reduction in costs for these costly drugs.
Comment: Let’s hope these work as well as the brand name drugs.